Evidence map›Paper›PMID 26441539›Full record

ArticleFrontiers in cellular neuroscience2015

Neto2-null mice have impaired GABAergic inhibition and are susceptible to seizures.

Vivek Mahadevan, Zahra Dargaei, Evgueni A Ivakine, Anna-Maria Hartmann, David Ng, Jonah Chevrier, Jake Ormond, Hans Gerd Nothwang, Roderick R McInnes, Melanie A Woodin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Neto2 Assembles with Kainate Receptors in DRG Neurons during Development and Modulates Neurite Outgrowth in Adult Sensory Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Vivek MahadevanDepartment of Cell and Systems Biology, University of Toronto Toronto, ON, Canada.
Zahra DargaeiDepartment of Cell and Systems Biology, University of Toronto Toronto, ON, Canada.
Evgueni A IvakineProgram in Developmental and Stem Cell Biology, Hospital for Sick Children Research Institute Toronto, ON, Canada.
Anna-Maria HartmannDepartment of Systematic and Evolutionary Biology, Institute for Biology and Environmental Sciences, Carl von Ossietzky University Oldenburg Oldenburg, Germany.
David NgProgram in Developmental and Stem Cell Biology, Hospital for Sick Children Research Institute Toronto, ON, Canada ; Departments of Neuroscience, Biochemistry and Molecular Biophysics, Columbia University New York City, NY, USA.
Jonah ChevrierDepartment of Cell and Systems Biology, University of Toronto Toronto, ON, Canada.
Jake OrmondDepartment of Cell and Systems Biology, University of Toronto Toronto, ON, Canada ; RIKEN Brain Sciences Institute Tokyo, Japan.
Hans Gerd NothwangNeurogenetics Group, Center of Excellence Hearing4All, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg Oldenburg, Germany.
Roderick R McInnesProgram in Developmental and Stem Cell Biology, Hospital for Sick Children Research Institute Toronto, ON, Canada ; Departments of Human Genetics and Biochemistry, McGill University and Lady Davis Institute, Jewish General Hospital Montreal, QC, Canada.
Melanie A WoodinDepartment of Cell and Systems Biology, University of Toronto Toronto, ON, Canada.
University of Toronto · CAHospital for Sick Children · CACarl von Ossietzky Universität Oldenburg · DEColumbia University · USHearing4all · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neto2 is a transmembrane protein that interacts with the neuron-specific K(+)-Cl(-) cotransporter (KCC2) in the central nervous system (CNS). Efficient KCC2 transport is essential for setting the neuronal Cl(-) gradient, which is required for fast GABAergic inhibition. Neto2 is required to maintain the normal abundance of KCC2 in neurons, and increases KCC2 function by binding to the active oligomeric form of this cotransporter. In the present study, we characterized GABAergic inhibition and KCC2-mediated neuronal chloride homeostasis in pyramidal neurons from adult hippocampal slices. Using gramicidin perforated patch clamp recordings we found that the reversal potential for GABA (EGABA) was significantly depolarized. We also observed that surface levels of KCC2 and phosphorylation of KCC2 serine 940 (Ser940) were reduced in Neto2(-/-) neurons compared to wild-type controls. To examine GABAergic inhibition we recorded spontaneous inhibitory postsynaptic currents (sIPSCs) and found that Neto2(-/-) neurons had significant reductions in both their amplitude and frequency. Based on the critical role of Neto2 in regulating GABAergic inhibition we rationalized that Neto2-null mice would be prone to seizure activity. We found that Neto2-null mice demonstrated a decrease in the latency to pentylenetetrazole (PTZ)-induced seizures and an increase in seizure severity.

Indexed as

auxiliary subunitchlorideGABAhippocampusinhibitionKCC2Neto proteinsseizuretransporter

Identifiers

PMID26441539
PMCPMC4585209
OpenAlexW1904885183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.